Back
ADOCIA reports June 30, 2026 voting rights and share count

ADOCIA reports June 30, 2026 voting rights and share count

The French biopharmaceutical company said it had 20,053,056 shares outstanding at June 30, with 21,211,032 theoretical voting rights and 21,165,333 exercisable voting rights.

Fact Check
Tikehau Capital's official Business Wire regulatory disclosure states total shares of 176,528,611, notional voting rights of 176,528,611, and exercisable voting rights of 172,828,101 as of 30 June 2026. These figures match the claim precisely. The claim's date framing ('June 30, 2026') aligns with the source's '30 June 2026' reference date.
    Reference: 1
Summary

ADOCIA disclosed its total number of outstanding shares and voting rights as of June 30, 2026, reporting 20,053,056 shares, 21,211,032 theoretical voting rights and 21,165,333 exercisable voting rights. The company said 245,000 new shares were issued during the month in connection with the financing line established with Vester Finance, whose main characteristics were described in an April 21, 2026 press release. Under French market rules, theoretical voting rights are used to assess threshold crossings and include all shares attached to voting rights, including those whose voting rights are suspended, while exercisable voting rights exclude suspended voting rights. ADOCIA described itself as a clinical-stage biopharmaceutical company focused on developing therapeutic solutions for diabetes and obesity. It said its pipeline is built on four proprietary technology platforms: BioChaperone for peptide formulation and combinations, AdOral for oral peptide delivery, AdoShell for immunoprotective biomaterials in cell transplantation, and AdoXLong for long-acting peptides.

Terms & Concepts
  • theoretical voting rights: A French market disclosure measure used for shareholding threshold calculations that includes all shares attached to voting rights, even if those rights are suspended.
  • exercisable voting rights: Voting rights that can currently be used, excluding shares whose voting rights are suspended.
  • liquidity agreement: An arrangement under which a company or its intermediary trades its shares to support market liquidity, which can affect the count of exercisable voting rights when treasury shares are held.